biotech · Breast Cancer · Sarcoma,Soft Tissue · INTS
INTENSITY THERAPEUTICS
INTENSITY THERAPEUTICS, INC.
Intensity Therapeutics is a biotech organization headquartered in Shelton, USA. It trades on NYSE under ticker INTS. Primary therapeutic focus areas include Breast Cancer, Sarcoma,Soft Tissue, EGFR Mutant Advanced Non-sm
Shelton, USA HQ
2012 Founded
12 Employees
Public company Type
INTS · NYSE Ticker
Company details
- Status
- Public
- HQ
- Shelton, USA
- Founded
- 2012
- Employees
- 12
- Programs
- 6
- Drugs
- 9
- Patents
- 3
INT230-6
Phase 3 · small molecule · Sarcoma,Soft Tissue
INT230-6 for Sarcoma,Soft Tissue is a Phase 3 program (small_molecule) at INTENSITY THERAPEUTICS, INC. with 1 ClinicalTrials.gov record(s).
Internal code IT-03
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- INTENSITY THERAPEUTICS, INC.
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- Sarcoma,Soft Tissue
- Status
- active
- Trials
- 1